[Three-dimensional brachytherapy optimization techniques in the treatment of patients with cervix cancer].
Traditionally, prescription and treatment planning in intracavitary brachytherapy for cervix cancer have used either reference points (mainly points A and B) or reference isodoses (60Gy according to ICRU recommendations) to report doses to the target volume. Doses to critical organs were reported at bladder and rectum ICRU points. This practice has been supported by a long-standing clinical experience that has yielded an acceptable therapeutic ratio. The recent development of imaging has contributed to the improvement in target and organs at risk knowledge. In 2005 and 2006, GEC-ESTRO recommendations publications on 3-D based image brachytherapy have defined the different volumes of interest. These recommendations have been validated with intercomparison delineation studies. With the concomitant development of remote after-loading projectors, provided with miniaturized sources, it is now possible to plan radiation doses by adjusting dwell positions and relative dwell time values. These procedures allow better coverage of the targets while sparing OAR. The recent literature data evidence a significant improvement in local control with no increase in complications. Further studies are needed to better define the dose recommended in both tumour and organs at risk. This is one of the goals of the European study on MRI-guided brachytherapy in locally advanced cervical cancer (EMBRACE) protocol.
Haie-Meder
C
C
Service de Curiethérapie, Institut Gustave-Roussy, 94800 Villejuif, France. christine.haie@igr.fr
Mazeron
R
R
Verezesan
O
O
Dumas
I
I
Monnier
L
L
Vieillot
S
S
Lhommé
C
C
Morice
P
P
Barillot
I
I
D001918:Brachytherapy / Q000379:methods*; D005260:Female; D006801:Humans; D008279:Magnetic Resonance Imaging / Q000379:methods; D011879:Radiotherapy Dosage; D012007:Rectum / Q000473:pathology / Q000528:radiation effects; D001743:Urinary Bladder / Q000473:pathology / Q000528:radiation effects; D002583:Uterine Cervical Neoplasms / Q000473:pathology / Q000532:radiotherapy*